MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Medtech in a Minute: Axonics Contests Medtronic Patents, COVID-19 Rages on, and More Image by OpenClipart-Vectors on Pixabay
Your time is valuable, so we've drilled down the three most important medtech stories from the past week. But feel free to click the headline to read beyond the blurb.

Medtech in a Minute: Axonics Contests Medtronic Patents, COVID-19 Rages on, and More

Pressed for time? Here's the medtech news you need most, in one minute or less.

Fears of ventilator shortages prompts swift FDA action

On Sunday, FDA issued an immediately-in-effect policy intended to help increase availability of ventilators and their accessories as well as other respiratory devices during the COVID-19 pandemic. The guidance, issued without a public comment period, is intended to foster the continued availability of the devices while being flexible regarding manufacturer modifications made to ventilators, anesthesia gas machines, and other respiratory devices, and their accessories, in response to the COVID-19 public health emergency.

New tests, production increases, and Funding

Thermo Fischer Scientific and Abbott Laboratories joined Roche Diagnostics on a growing list of companies that have received emergency use authorizations (EUAs) from FDA for tests designed to detect coronavirus (COVID-19). BD (Becton, Dickinson and Company) is working with BioGx to request an EUA for a COVID-19 test and ramping up production of its collection devices. Meanwhile, a startup company called E25Bio managed to score $2 million in funding from Khosla Ventures to pursue its COVID-19 test.

Axonics-Medtronic battle rages on

In response to Medtronic's patent infringement claims, filed in November, Axonics Modulation Technologies is contesting the validity of each patent Medtronic has accused it of infringing. Axonics filed seven petitions with the U.S. Patent and Trademark Office (USPTO) requesting an inter partes review of each of the Medtronic patents in question. It could take up to 18 months for the USPTO to render a decision.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.